PGR and cancer: In estrogen receptor (ER) and progesterone receptor (PR) positive MCF7 cells and triple negative breast cancer cells (BT20 and MDA-MB-468), overexpression of OCT3 was related to enhanced metformin uptake and anti-tumor efficacy, indicating that OCT3 supported the movement of metformin into the cancer cell [61].